Anna Majowicz

Anna Majowicz

Company: Spark Therapeutics

Job title: Preclinical Immunology Lead


Overcoming Innate Immune Barriers That Can Impede AAV Gene Therapy Vectors 2:30 pm

Overview of innate immune responses in AAV-based gene therapy Discuss the role of complement system in AAV immunogenicity Examining potential immunomodulatory strategies to circumvent AAV related immune responsesRead more

day: Day 1 Tracks 1 PM

Industry Leaders Panel Discussion: Addressing High Dose AAV Delivery 9:30 am

Have we reached the highest dose for gene therapy yet? Exploring dosing strategies: “One and done or Slower and Lower?” What impact would a cumulative vector genome delivery approach have on safety and efficacy? Moving away from one and done: what does best practice look like for dosing strategies? Which role does complement play in…Read more

day: Day One

Chair’s Opening Remarks 8:50 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.